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Fig 1. Phototesting in a patient with solar urticaria
following light-emitting diode therapy. Erythema and
edema were observed 5 minutes after exposure to visible
light (left) and 415 nm blue light (right).
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e74 Letterslenalidomide maintenance therapy was initiated in
addition to zoledronic acid at tri-monthly intervals
for the prevention of skeletal fractures. At her
3-month bone marrow biopsy and 1-year follow-
up following stem cell transplantation, the patient
continued to be in a stringent complete first
response. She continues to tolerate maintenance
treatment well and follows up with her oncologist
intermittently.
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To the Editor: Light Emitting Diodes (LEDs) are
increasingly used for many conditions, including
wound healing and treatment of photoaging skin.
They are said to be a safe procedure without side
effects. We report a case of solar urticaria to visible
light induced by LED therapy.
A 55-year-old woman with no history of urticarial
rash following previous sun exposures was treated
with a 415-nm LED for mild rosacea. During the LED
exposure an intense urticarial reaction of the face
with burning sensation developed on her face
necessitating discontinuation of the session. There
were no concomitant respiratory or digestive
symptoms. Following this session, she reported a
photosensitivity that impaired her quality of life, andOpen access under CC BY-NC-ND license.she was referred to our department. Results of
routine laboratory blood studies were normal,
including antinuclear antibodies and porphyrin
levels. The patient was phototested in the solar UV
domain using a solar simulator (Oriel Newport,
model 92292, high-pressure Xenon lamp) with a
WG320/1.6 mm and UG11/1 mm filter combination
(no visible light emitted). Phototests in UVB and UVA
spectrum (exposure to six increasing doses, from
9.2 mJ/cm2 to 28.2 mJ/cm2) and UVA spectrum alone
(33 J/cm2) did not induce any abnormal reaction. On
the contrary, explorations using total visible light
(ultra-high-pressure mercury lamp, 126 J/cm2) as
well as blue light (wavelength 415 nm, 42.3 J/cm2)
induced an erythematous and edematous reaction at
the end of exposure, with itching and burning
sensations (Fig 1). Thus, phototesting confirmed
the diagnosis of solar urticaria to visible light induced
by blue LED therapy. Antihistamines combined with
hydroxychloroquine and use of a broad-spectrum
sunscreen did not improve the solar urticaria.
A desensitization phototherapy, according to a
well-defined protocol,1 allowed a marked regression
of the symptoms.
Initially used for their healing properties, LEDs
have many well demonstrated biological effects
in vitro that suggest they have potential therapeu-
tic value. However, it is difficult to extrapolate
these in vitro data to clinical practice because
many factors must be taken into consideration,
such as wavelength, irradiance, and the interac-
tion with whole human skin.2 Unfortunately,
except in cases of wound healing, clinical studies
of good methodology are lacking.3,4 Despite the
absence of clinical evidence, use of LEDs is
becoming increasingly popular. Their safety pro-
file is described as excellent in the literature; only
cautions concerning epileptic and photophobic
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lessness has favored the development of this
technique, not only among dermatologists but
also among other specialists. Its use today extends
beyond the medical field, and several beauty
salons also offer LED therapy.
Solar urticaria is a rare form of physical urticaria
induced by sun exposure and must be distinguished
from other photodermatoses. The condition can be
disabling and remains difficult to manage. Our case
suggests that solar urticaria is a previously unrecog-
nized side effect of LED therapy that physicians
should be aware of. This case also pleads for clinical
studies with robust methodologic quality to explore
the efficacy and side effects of LEDs in dermatologic
indications.
Our gratitude to Jane Esdaile for revising the
letter.
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stannous fluoride in toothpaste
To the Editor: A 55-year-old woman presented with
recurrent idiopathic urticaria and cheilitis. Her symp-
toms began 2 years ago following dental work, with
intermittent lip swelling and daily hives occurring
over 10 months. She received 5- to 7-day tapered
courses of 40 mg prednisone on 8 occasions during
this time, and her symptoms ultimately remitted
spontaneously. Prior allergy workup for urticaria,
including patch testing (via TRUE test) was mildly
positive only for thimerosal and fragrance. Prick
testing for environmental allergens was negative.
One month before initial evaluation, the patient
underwent implantation of newdental resin fillings in
place of older amalgam fillings. She tolerated lido-
caine during the procedure without difficulty. The
patient awoke 6 hours later with lip and oral swelling.
On presenting to the emergency department, she
received epinephrine and intravenous steroids, and
completed a course of prednisone. In the weeks
thereafter, she continued to experience intermittent
lip swelling, facial dermatitis, and urticaria.
She consulted the allergy clinic. Pulmonary func-
tion testing revealed normal spirometry; skin prick
testing and intradermal testing with lidocaine, mepi-
vacaine, and proparacaine yielded negative results.
Based on the temporal correlation between her
dental work and symptom onset, the patient was
referred for expanded patch testing. Immediate
patch testing interpretation to detect urticaria was
not performed. Testing results at 96 hours revealed
no positive reactions to fragrance or flavoring
chemicals. The patient had 11 methyldibromoglu-
taronitrile, 11 lidocaine, 11 dodecyl gallate, and
11 tin reactions (Fig 1). Lidocainewas relevant to her
episode of oral swelling occurring hours after her
dental procedure. The reactions to dodecyl gallate
and methyldibromoglutaronitrile were not relevant.
It is possible that the patient’s persistent symptoms
occurred due to allergy to tin. Her exposures included
prior amalgam dental fillings (which typically contain
mercury, silver, copper, and tin) and Crest Pro-Health
toothpastewith the active ingredient stannous fluoride
(Tin (II) fluoride). Upon discontinuation of this tooth-
paste, the patient’s episodic lip swelling and urticaria
resolved. Shewas symptom-free for 8 weeks, when an
inadvertent reexposure to the same toothpaste was
associated with recurrence of urticaria and lip swelling
within a few hours. After subsequent avoidance of the
suspected toothpaste, she again experienced remis-
sion of symptoms. We postulate that the stannous
fluoride in the toothpaste may be the cause of her
urticaria, although it is possible that another ingredient,
such as a flavoring agent, is responsible.
